Overall, this study establishes a clear functional connection between MYC suppression and DDR pathway targeting, offering a concrete example of how direct MYC inhibitors can potentiate existing therapeutic strategies that exploit replication stress and repair dependency in cancer cells. The gene discussed is MYC; the disease is cancer.